Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Orthofix Medical Inc. - Common Stock (NQ:OFIX)

14.68 -1.38 (-8.59%)
Streaming Delayed Price Updated: 3:40 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orthofix Medical Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Orthofix Medical Inc (NASDAQ:OFIX) Surpasses Q3 2025 Profit Expectations Despite Muted Market Reaction
Orthofix (OFIX) Q3 2025 earnings beat estimates with $0.20 EPS vs. $(0.41) forecast. Revenue of $205.6M also surpassed expectations, driven by strong spine and orthopedics growth. 
Via Chartmill
Topics Earnings
Orthofix Reports Third Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
Earnings Scheduled For November 4, 2025
 
Via Benzinga
Insights Ahead: Orthofix Medical's Quarterly Earnings
 
Via Benzinga
Orthofix to Participate in Upcoming Investor Conferences
From Orthofix Medical Inc.
Via Business Wire
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Earnings Scheduled For May 6, 2025
 
Via Benzinga
Earnings Scheduled For February 25, 2025
 
Via Benzinga
Top 2 Health Care Stocks That May Crash In February
 
Via Benzinga
Orthofix to Report Third Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage
Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target. 
Via Benzinga
Orthofix (OFIX) Q2 Revenue Rises 2%
Via The Motley Fool
Orthofix Reports Second Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference
From Orthofix Medical Inc.
Via Business Wire
Orthofix to Report Second Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System
From Orthofix Medical Inc.
Via Business Wire
Orthofix Reports First Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
Orthofix to Report First Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
Orthofix Receives 510(k) Clearance and CE Mark for TrueLok Elevate Transverse Bone Transport System
From Orthofix Medical Inc.
Via Business Wire
Orthofix Announces Appointment of Vickie Capps to Board of Directors
From Orthofix Medical Inc.
Via Business Wire
Orthofix to Participate in the 37th Annual Roth Conference
From Orthofix Medical Inc.
Via Business Wire
Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance
From Orthofix Medical Inc.
Via Business Wire
Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference
From Orthofix Medical Inc.
Via Business Wire
Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
From Orthofix Medical Inc.
Via Business Wire
This Analyst Says Orthopedic-Focused Orthofix Medical Is Positioned For Growth
Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook. 
Via Benzinga
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
 
Via Benzinga
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Orthofix to Participate in Upcoming Investor Conferences
From Orthofix Medical Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.